share_log

赛生药业公布授出的2万份购股权已获行使

Saisheng Pharmaceutical announced that the 20,000 share options granted have been exercised

新浪港股 ·  May 16 20:42

Saisheng Pharmaceutical (06600) announced that on May 16, 2024, 20,000 share options granted under the initial public offering after-sales share option plan have been exercised in accordance with the rules of the initial public offering after-sales share option plan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment